XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital Hyperinsulinism Oct 19, 2016 9:00am EDT
XOMA to Host XOMA 358 Clinical Update Webcast and Conference Call on September 15, 2016 Sep 06, 2016 9:00am EDT
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism Jul 20, 2016 9:00am EDT
